Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6285308

O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.c1ccc2sc(SCCN3CCNCC3)nc2c1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
MAPK1 P28482 3/20 0.53
HPGD P15428 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
POLB P06746 2/20 0.53
TSHR P16473 2/20 0.53
HSD17B10 Q99714 2/20 0.53
SOAT1 P35610 3/20 0.52
CYP1A2 P05177 3/20 0.49
CYP2D6 P10635 2/20 0.49
NPC1 O15118 1/20 0.47
MAPT P10636 1/20 0.47
RAB9A P51151 1/20 0.47
APEX1 P27695 1/20 0.47
RECQL P46063 1/20 0.47
ALOX5 P09917 2/20 0.47
CYP2C19 P33261 2/20 0.46
IDO1 P14902 1/20 0.46
USP2 O75604 1/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1704721 0.88 CYP1A2 (0.60) ALDH1A1MAPK1HPGDSMN1; SMN2POLB
SCHEMBL14761267 0.82 CYP1A2 (0.58) ALDH1A1MAPK1SMN1; SMN2CYP1A2CYP2D6
Trifluoroacetic Acid SCHEMBL6282185 0.78 RAB9A (0.60) ALDH1A1SMN1; SMN2TSHRSOAT1CYP1A2
Trifluoroacetic Acid SCHEMBL1705470 0.77 SOAT1 (0.52) ALDH1A1MAPK1HPGDSMN1; SMN2POLB
SCHEMBL5076188 0.74 SOAT1 (0.55) ALDH1A1MAPK1HPGDSMN1; SMN2POLB
Trifluoroacetic Acid SCHEMBL7857078 0.74 POLB (0.55) ALDH1A1MAPK1HPGDSMN1; SMN2POLB
SCHEMBL14761750 0.74 SMN1; SMN2 (0.57) ALDH1A1MAPK1HPGDSMN1; SMN2POLB
Trifluoroacetic Acid SCHEMBL5623338 0.72 ALDH1A1 (0.40) ALDH1A1SOAT1CYP1A2NPC1RAB9A
Trifluoroacetic Acid SCHEMBL6280105 0.71 SOAT1 (0.53) ALDH1A1MAPK1HPGDPOLBTSHR
SCHEMBL18797537 0.71 SMN1; SMN2 (0.64) ALDH1A1MAPK1HPGDSMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6969711-B2 Cyclic diamine compounds and medicine containing the same KOWA COMPANY, LTD. (JP) 2005-11-29 US disclosed
EP-0987254-B1 NOVEL CYCLIC DIAMINE COMPOUNDS AND MEDICINE CONTAINING THE SAME KOWA CO (JP) 2004-12-22 EP disclosed
US-20040038987-A1 Novel cyclic diamine compounds and medicine containing the same KOWA COMPANY, LTD. (JP) 2004-02-26 US disclosed
EP-0987254-A1 NOVEL CYCLIC DIAMINE COMPOUNDS AND MEDICINE CONTAINING THE SAME Kowa Co., Ltd. (JP) 2000-03-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038987-A1 Novel cyclic diamine compounds and medicine containing the same LCAT, ACAT2, ACAT1 ALDH1A1 307/4885MAPK1 1160/4885HPGD 939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.